Understanding how gene regulation affects brain cell recovery in vascular dementia
Epigenetic Regulation of Oligodendrocyte Regeneration in Subcortical Ischemic Vascular Dementia
This study is looking at how certain changes in our genes might help brain cells called oligodendrocytes heal and grow back, which could be really helpful for people with subcortical ischemic vascular dementia, a condition that affects thinking and memory.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10509535 on NIH RePORTER |
What this research studies
This research investigates the role of epigenetic regulation in the regeneration of oligodendrocytes, which are crucial for brain health, particularly in patients suffering from subcortical ischemic vascular dementia (SIVD). The study aims to uncover how changes in gene expression influence the ability of oligodendrocyte precursor cells to differentiate and repair white matter damage caused by reduced blood flow to the brain. By exploring these cellular and molecular mechanisms, the research seeks to identify potential therapeutic targets for improving cognitive function in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults diagnosed with subcortical ischemic vascular dementia who are experiencing cognitive decline.
Not a fit: Patients with other forms of dementia not related to vascular issues or those without cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance brain cell recovery and improve cognitive function in patients with vascular dementia.
How similar studies have performed: Previous research has shown promising results in understanding the role of epigenetic mechanisms in neurodegenerative diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Arai, Ken — Massachusetts General Hospital
- Study coordinator: Arai, Ken
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.